Additionally, it addresses the FDA’s communications Using the applicant, the retention of data that assistance the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer ownership of the SE report to a different applicant and Digital submission with the SE report and amendmen